̽»¨Ö±²¥

Scientists at the ̽»¨Ö±²¥ of Cambridge have identified a key chemical that can repair the damage to cells which causes a rare but devastating disease involving accelerated ageing. As well as offering a promising new way of treating the condition, known as Hutchinson-Gilford Progeria Syndrome (HGPS), the discovery could help in the development of drugs against cancer and other genetic diseases and might also suggest ways to alleviate diseases that we associate with normal ageing.

New research shows that, contrary to what was previously assumed, suppressing unwanted memories reduces their influence on behaviour, and sheds light on how this process happens in the brain.

A new therapy for peanut allergy has been successful in the majority of the 99 children who took part in a clinical trial.

̽»¨Ö±²¥path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.